These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 10495134)

  • 1. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
    Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of treatment for 3 months with human parathyroid hormone 1-34 peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Johnson CS; Lees CJ
    Bone; 1995 Oct; 17(4 Suppl):415S-420S. PubMed ID: 8579946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Burr DB; Van Bibber T; Hock JM; Brommage R
    Bone; 2001 Feb; 28(2):150-9. PubMed ID: 11182372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys.
    Brommage R; Hotchkiss CE; Lees CJ; Stancill MW; Hock JM; Jerome CP
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3757-63. PubMed ID: 10523026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.
    Fox J; Miller MA; Newman MK; Recker RR; Turner CH; Smith SY
    Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
    Fox J; Miller MA; Recker RR; Turner CH; Smith SY
    Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry.
    Jerome CP; Carlson CS; Register TC; Bain FT; Jayo MJ; Weaver DS; Adams MR
    J Bone Miner Res; 1994 Apr; 9(4):527-40. PubMed ID: 8030441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
    Fox J; Miller MA; Newman MK; Turner CH; Recker RR; Smith SY
    J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
    Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
    Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
    Jerome CP; Power RA; Obasanjo IO; Register TC; Guidry M; Carlson CS; Weaver DS
    Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
    Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
    Bone; 2016 May; 86():43-52. PubMed ID: 26921823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoride treatment increased serum IGF-1, bone turnover, and bone mass, but not bone strength, in rabbits.
    Turner CH; Garetto LP; Dunipace AJ; Zhang W; Wilson ME; Grynpas MD; Chachra D; McClintock R; Peacock M; Stookey GK
    Calcif Tissue Int; 1997 Jul; 61(1):77-83. PubMed ID: 9192519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
    Sato M; Westmore M; Ma YL; Schmidt A; Zeng QQ; Glass EV; Vahle J; Brommage R; Jerome CP; Turner CH
    J Bone Miner Res; 2004 Apr; 19(4):623-9. PubMed ID: 15005850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of androstenedione/estrone supplementation on cortical and cancellous bone in the young intact female monkey: a model for the effects of polycystic ovarian disease on the skeleton?
    Lundon KM; Jayo MJ; Register TC; Dumitriu M; Grynpas MD
    Osteoporos Int; 2000; 11(9):778-89. PubMed ID: 11210841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
    Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.
    Hansen S; Hauge EM; Beck Jensen JE; Brixen K
    J Bone Miner Res; 2013 Apr; 28(4):736-45. PubMed ID: 23044908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.